Original Article
Efficacy of Elbasvir/Grazoprevir in Early Chronic G1/G4 Hepatitis C infection in HIV/HCV co-infected patients with mild fibrosis
Eficacia de elbasvir/grazoprevir en la infección por hepatitis C crónica reciente G1/G4 en pacientes coinfectados por el VIH/VHC con fibrosis leve
Read
528
Timeswas read the article
117
Total PDF
411
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2024 December | 11 | 1 | 12 |
| 2024 November | 18 | 8 | 26 |
| 2024 October | 10 | 5 | 15 |
| 2024 September | 21 | 5 | 26 |
| 2024 August | 19 | 4 | 23 |
| 2024 July | 9 | 6 | 15 |
| 2024 June | 13 | 2 | 15 |
| 2024 May | 21 | 5 | 26 |
| 2024 April | 14 | 1 | 15 |
| 2024 March | 32 | 6 | 38 |
| 2024 February | 33 | 1 | 34 |
| 2024 January | 28 | 2 | 30 |
| 2023 December | 20 | 4 | 24 |
| 2023 November | 18 | 5 | 23 |
| 2023 October | 26 | 6 | 32 |
| 2023 September | 15 | 2 | 17 |
| 2023 August | 8 | 5 | 13 |
| 2023 July | 15 | 3 | 18 |
| 2023 June | 19 | 12 | 31 |
| 2023 May | 6 | 3 | 9 |
| 2023 April | 9 | 3 | 12 |
| 2023 March | 6 | 2 | 8 |
| 2022 November | 3 | 3 | 6 |
| 2022 October | 5 | 5 | 10 |
| 2022 September | 4 | 4 | 8 |
| 2022 August | 5 | 7 | 12 |
| 2022 July | 1 | 1 | 2 |
| 2022 June | 1 | 2 | 3 |
| 2022 May | 1 | 0 | 1 |
| 2022 April | 4 | 0 | 4 |
| 2021 November | 0 | 2 | 2 |
| 2021 July | 1 | 0 | 1 |
| 2021 June | 3 | 0 | 3 |
| 2021 April | 2 | 0 | 2 |
| 2021 March | 1 | 2 | 3 |
| 2021 February | 9 | 0 | 9 |
Show all
